Sign In
Buy ALDX
$1.86
+0.220 (+13.41%)
At Close: Jun 03, 2026
Aldeyra Therapeutics, Inc. (ALDX) Upgraded to Buy: Here's What You Should Know
04:00pm, Wednesday, 12'th Aug 2020
Aldeyra Therapeutics, Inc. (ALDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Aldeyra's (ALDX) Q2 Earnings Beat Estimates, Pipeline in Focus
02:09pm, Thursday, 06'th Aug 2020
Aldeyra (ALDX) reports narrower-than-expected loss in the second quarter of 2020.
Aldeyra Therapeutics Announces Second-Quarter 2020 Financial Results and Provides Corporate Update
11:00am, Thursday, 06'th Aug 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immun
Aldeyra (ALDX) to Report Q2 Earnings: What's in the Offing?
02:07pm, Tuesday, 04'th Aug 2020
Aldeyra's (ALDX) pipeline progress will be in focus when it reports Q2 results later in the week.
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
12:00pm, Tuesday, 04'th Aug 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that senior management will be presenting and hosting 1x1 meetings at the following virtual investor conferences in August:
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Expected to Post Earnings of -$0.34 Per Share
06:18am, Tuesday, 04'th Aug 2020
Equities research analysts expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX) to post earnings of ($0.34) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Aldeyra Th
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Down 8.7% in July
03:46am, Tuesday, 04'th Aug 2020
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 574,100 shares, a decrease of 8.7% from t
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
12:00am, Tuesday, 04'th Aug 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that senior management will be presenting and hosting 1x1 meetings at the followin
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second-Quarter 2020 Financial Results and Corporate Update
12:00pm, Thursday, 30'th Jul 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immun
Two Sigma Advisers LP Boosts Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)
11:26pm, Wednesday, 15'th Jul 2020
Two Sigma Advisers LP lifted its stake in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) by 239.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange
Aldeyra Therapeutics Announces Stock Sales to Perceptive Advisors and Avidity Partners
12:00pm, Tuesday, 14'th Jul 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today a
Aldeyra Spikes 10% In Pre-Market On New Perceptive Stake
08:32am, Tuesday, 14'th Jul 2020
Shares in Aldeyra Therapeutics (ALDX) are climbing 10% in Tuesday’s pre-market trading following a SEC filing showing that Joseph Edelman’s Perceptive Advisors now holds a 19.1% in the company.Ac
Aldeyra Therapeutics to Present at the OIS Virtual Public Company Showcase on July 16, 2020
08:05pm, Monday, 13'th Jul 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will discuss the company’s clinical programs in anterior a
Aldeyra Therapeutics to Present at the OIS Virtual Public Company Showcase on July 16, 2020
12:00am, Monday, 13'th Jul 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will discu
Aldeyra Therapeutics (NASDAQ:ALDX) Trading Down 7.3%
03:36am, Sunday, 12'th Jul 2020
Aldeyra Therapeutics, Inc (NASDAQ:ALDX)’s stock price was down 7.3% during trading on Friday . The stock traded as low as $4.79 and last traded at $4.82, approximately 2,173,900 shares were traded d
